RxDoctor Payments Data

Rachel Dalthorp

Neurology · Moore, OKNPI 1811218803

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $72,685 of the $116,355 with a category attached, or 62.5%. Johnson & Johnson accounts for 85.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $57,380 and has fallen 95.1% since, to $2,796 in 2025. Among neurology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$116,355in general payments, 2019–2025

Across 210 payments — averaging $554.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$100K
  • Sage Therapeutics, LLC$10K
  • Biogen$5K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
  • Neuronetics, Inc.$436
  • AbbVie$139
  • plus $45 from 3 others

What the payments were for

  • Consulting fees$32,29428%
  • Speaking & faculty fees$72,68562%
  • Travel & lodging$7,5306%
  • Food & beverage$3,8463%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$116,355 in reported general payments places this provider in the 90th percentile of 152 neurology providers in Oklahoma.

See all neurology providers in Oklahoma

Other neurology in Moore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →